ENDOMETRIAL CANCER: INITIAL RESULTS OF CONSERVATIVE HORMONAL TREATMENT IN POSTMENOPAUSAL PATIENTS IN ONCOLOGY HOSPITALS OF BUENOS AIRES

被引：0
|
作者：
Soderini, P. [1 ]
Depietri, V. [1 ]
Crespe, M. [1 ]
Horacio, M. [1 ]
Martin, M. [1 ]
Rosa, G. [1 ]
Aragona, A. [1 ]
机构：
[1] Hosp Marie Curie, Buenos Aires, DF, Argentina
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2020年 / 30卷
关键词：
D O I：
10.1136/ijgc-2020-IGCS.241
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCS20_129
引用
收藏
页码：A114 / A114
页数：1
相关论文
共 50 条
  • [31] Initial Cancer Treatment in Certified Versus Non-certified Hospitals: Results of the WiZen Comparative Cohort Study
    Hanisch, Ernst
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2024, 121 (06):
  • [32] CONTINUOUS TAMOXIFEN TREATMENT IN ASYMPTOMATIC, POSTMENOPAUSAL BREAST-CANCER PATIENTS DOES NOT CAUSE AGGRAVATION OF ENDOMETRIAL PATHOLOGIES
    COHEN, I
    TEPPER, R
    ROSEN, DJD
    SHAPIRA, J
    CORDOBA, M
    DROR, Y
    ALTARAS, M
    BEYTH, Y
    GYNECOLOGIC ONCOLOGY, 1994, 55 (01) : 138 - 143
  • [33] The influence of quality in processes and results within studies in oncology treatment of patients with rectal cancer
    Fleck, U
    Schischke, F
    Hecker, HP
    ZENTRALBLATT FUR CHIRURGIE, 2000, 125 : 169 - 171
  • [34] SURVIVAL OF PATIENTS WITH INCIDENTALLY FOUND MICROSCOPIC CANCER OF PROSTATE - RESULTS OF A CLINICAL TRIAL OF CONSERVATIVE TREATMENT
    BYAR, DP
    JOURNAL OF UROLOGY, 1972, 108 (06): : 908 - &
  • [35] Real-world data on initial treatment strategies for older adult patients with endometrial cancer in Japan
    Mayu Yunokawa
    Shinsuke Sasada
    Yae Takehara
    Kenta Takahashi
    Tatsunori Shimoi
    Kan Yonemori
    Mitsuya Ishikawa
    Tomoyasu Kato
    Kenji Tamura
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 1051 - 1058
  • [36] Real-world data on initial treatment strategies for older adult patients with endometrial cancer in Japan
    Yunokawa, Mayu
    Sasada, Shinsuke
    Takehara, Yae
    Takahashi, Kenta
    Shimoi, Tatsunori
    Yonemori, Kan
    Ishikawa, Mitsuya
    Kato, Tomoyasu
    Tamura, Kenji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (05) : 1051 - 1058
  • [37] Which of postmenopausal metastatic breast cancer patients should be treated with fulvestrant in 3rd line hormonal treatment?
    Zbrzezniak, Jolanta
    Jagiello-Gruszfeld, Agnieszka I.
    Czerniawska, Malgorzata
    Szablowska-Siwik, Sylwia
    ANNALS OF ONCOLOGY, 2006, 17 : 87 - 88
  • [38] Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on letrozole or anastrozole. A phase II trial conducted by the Hellenic Group of Oncology (HELGO)
    Gennatas, C
    Michalaki, V
    Carvounis, E
    Psychogios, J
    Poulakaki, N
    Katsiamis, G
    Voros, D
    Kouloulias, V
    Mouratidou, D
    Tsavaris, N
    TUMORI JOURNAL, 2006, 92 (01): : 13 - 17
  • [39] How Spatial Accessibility to Radiation Oncology Services in Prostate Cancer Patients Influences Choice of Initial Treatment
    Kerba, M.
    Karosas, A.
    Wu, J. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S493 - S493
  • [40] Effect of demographic factors on brachytherapy treatment results in patients with endometrial cancer 1995-2010
    Jurczyk, Mieczyslawa U.
    Chmaj-Wierzchowska, Karolina
    Klofik, Joanna
    Sajdak, Stefan
    Opala, Tomasz
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2013, 20 (04) : 849 - 853
12345